CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,993,781
-0.7%
385,300
+23.7%
0.00%0.0%
Q2 2023$3,015,843
-10.1%
311,554
+1.8%
0.00%0.0%
Q1 2023$3,353,585
+158.1%
305,984
+1.8%
0.00%
Q4 2022$1,299,089
-41.7%
300,715
+1.5%
0.00%
-100.0%
Q3 2022$2,229,000
-25.1%
296,301
+0.0%
0.00%0.0%
Q2 2022$2,977,000296,2010.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders